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times and high tissue temperatures, resulting in unnecessary collateral tissue injury. This 
study tested the ability of bipolar RF energy to create transmural lesions on the beating 
heart that would permanently isolate atrial myocardium. 
METHODS: Baseline pacing on 6 dogs was performed on the following target areas: 
right and left atdal appendage, superior and inferior vena cavae, and right and left pulmo- 
nary veins. A cuff of atrial myocardium, proximal to the target tissue was clamped 
between the two arms of the bipolar device to produce continuous circumferential linear 
lesions from the epicardium. RF energy (86 Watts) was delivered until tissue cooduc- 
tanca between the electrodes fell to a stable minimal level of 0.0025 Mhos. Following 
ablation, pacing documented acute isolation. Animals were survived for 30 days and per- 
manent isolation was evaluated by pacing studies utilizing a 256-channel atrial mapping 
system. Histology was evaluated by H&E and Trichrome stain. 
RESULTS: 34 lesions were made at the initial surgery. Mean ablation time was 4.9 = 1.6 
seconds and mean peak tissue temperature was 46.6 = 3.0 °C. All lesions (34/34) 
acutely and permanently isolated atrial tissue. Mapping studies with pacing of atrial tis- 
sue on both sides of the lesion confirmed isolation. Histology demonstrated that all 
lesions were linear, continuous, and transmural with no thrombus formation or stenosis. 
The average maximum width for all lesions was 1.9 ± 0.7 mm (range 1.0 to 3.0). Lesions 
were produced up to a length of 50 mm and a depth of 8 mm. 
CONCLUSION: Bipolar RF energy rapidly produced permanent ransmural linear lesions 
on the beating heart with a single application. Real time measurement of tissue conduc- 
tance reliably predicted lesion transmurality. This new technology should enable a cura- 
tive minimally invasive operation for AF on the beating heart. 
1147-43 Does Off  Pump Coronary Artery Bypass Graft Surgery 
Reduce Poet-Operative Right Ventriculer Dysfunction? 
Balvinder S. Wasan. Niket Patal, Rex Stanbitdge, Brian Glenville, Simon Thorn, Rodney 
A. Foale, Jamil Mayer, Imperial College and St Mary's Hospital, London, United 
Kingdom. 
Background: Coronary artery bypass grafting (CABG) on the beating heart without car- 
dio-pulmonary bypass ('off pump') has gained increasing popularity. Numerous advan- 
tages over on-pump surgery, including improved post-operative ventricular function, have 
been cited. We compared the effect on postoperative ventricular function of the 2 meth- 
ods using tissue Doppler echocardiography (TDE). This technique allows the objective 
and non-invasive measurement of regional myocardial velocities. Methods: 20 patients 
with 3-vessel coronary artery disease undergoing elective CABG were included. 10 had 
on-pump and 10 had off-pump procedures. Each had pulsed wave TDE images obtained 
from the apex, providing visualisetion of the tricuspid free wall annulus and 4 regions of 
the mitral valve annulus. Systolic and diastolic velocities were compared immediately 
before and 5 days after surgery. Results: Both groups were comparable in terms of 
demographics and disease severity. All subjects had a left internal mammary artery graft 
with a mean of 2.5 vein grafts to the other vessels. All had a graft to the right coronary 
system. Compared to baseline, both on and off-pump groups showed a marked 
decrease in the right ventricular (RV) peak systolic and diastolic velocities (Table). While 
the reduction in velocities was less in the off-pump group, the difference between the two 
groups failed to reach statistical significance. Conclusions: There is significant RV dys- 
function after CABG with both on and off-pump techniques. 
Mean Change In Peak Velocity (cm/s) (*p<0.01 from baseline) 
RV Systolic RV Diastolic LV Systolic LV Diastolic 
Off-pump -6.5±1.2" -5.0=0.8" 0.4=0.4 0.8=0.7 
On-pump -5.2±1.3" -3.9=0.8* 0.4=0.6 0.9=0.8 
1147-44 Late Follow-Up of the Warm Heart Trial: Eight-Year 
Results 
Steve K. Sinah, Kathy Sykora, Jack V. Tu, C. D. Naylor, Christopher M. Feindel, Samuel 
V. Lichtenstein, Stephen E. Frames, Sunnybrook and Women's College Health Sciences 
Center, Toronto, Ontario, Canada, The Institute for Clinical Evaluative Sciences, Toronto, 
Ontario, Canada. 
Background: The Warm Heart Trial randomized 1,732 patients undergoing coronary 
artery bypass graft surgery to warm or cold blood cardioplegia. Warm patients had signif- 
icantly less non-fatal perioperative cardiac events and 30-day mortality was non-signifi- 
cantly decreased (1.4% vs. 2.5%, p=0.12). The purpose of this study was to evaluate the 
long-term outcomes of these patients to determine if different techniques for myocardial 
protection affect survival or hospital readmission for non-fatal, late cardiac events. Meth- 
ods: Late outcomes were obtained by merging clinical trial and population-based, admin- 
istrative databases. Results: Long-term outcomes were determined for 96% of the 
original patients. Median follow-up was 85 +/- 20 months for mortality, and 81 +/- 32 
months for mortality or hospital reedmission. Maximum follow-up was 101 months. Base- 
line clinical, angiographic and operative characteristics were similar between the Warm 
and Cold groups. Late survival was non-significantly greater in the Warm group (84.7 +/- 
1.4% vs. 82.4 +/- 1.6%, p=0.30) with an adjusted relative risk of 0.861 in multivariate 
models (95% confidence interval 0.668-1.109, p=0.25). Freedom from mortality or hospi- 
tal readmission for non-fatal late cardiac events was also non-signiticantly greater with 
warm cardioplegia (61.8 +/- 2.0% vs. 58.7 +/- 2.2%, p=0.74). Hospitalization for non-fatal 
late cardiac events was similar between cardioplegia types. Conclusions: Despite 
improved perioperative outcomes with warm cardioplegia, analysis of late outcomes did 
not demonstrate any substantial advantage over conventional methods of myocardial 
protection. 
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851-1 Effect of the Angiotensin II Type I Receptor Blocker 
Candesartan on Cardiovascular Events 
Junichiro Kondo, Takahito Sone, Hideyuki Tsuboi, Hiroaki Mukawa, Itsuro Modshima, 
Michitaka Uesugi, Takashi Kosaka, Tomohiro Yoshida, Ogaki Municipal Hospital, Ogaki, 
Japan. 
Background: Angiotensin II may play an important role in the pathogenesis of coronary 
artery disease. We assessed the effect of the angiotensin II receptor blocker candesertan 
in patients at high risk for cardiovascular events. Methods: A total of 406 patients were 
randomly and prospectively assigned to a candesartan group (4 mg/day) or a control 
group. All patients had a history of coronary intervention, and had no significant coronary 
stanosis on follow-up angiography 6 months after intervention. The primary endpoint was 
a composite of revasculaffzation, nonfatal myocardial infarction, or death from cardiovas- 
cular causes. The secondary endpoint was hospitalization due to cardiovascular causes 
(worsening angina or heart failure). Results: There were no differences between the two 
groups in clinical characteristics. Discontinuation of drug administration was required for 
only 9 patients, due to hypotansioo or dizziness. Neither the blood pressure at baseline 
nor that at follow-up differed between the groups. There were 62 cardiac events over a 
mean foUow-up period of 24 months. Treatment with csndesertan reduced primary end- 
point risk (6.2%, compared with 12.3% in the control group; relative risk, 0.49; 95 % con- 
fidence interval, 0.25 to 0.98; P=0.04) (revascularization occurred in 8 cases in the 
candesartan group and 15 cases in the control group, nonfatal myocardial infarction in 2 
and 1 cases, and death in 2 and 9 cases, respectively). The frequencies of secondary 
endpoints did not differ significant between the two groups (worsening angina occurred in 
9 cases in the candesertan group and 14 cases in the control group, and heart failure in 
0 and 2 cases, respectively). The frequencies of all cardiac events were significantly 
lower in the candesertan group (10.8%) than in the control group (20.2%, P=0.03). Con- 
clusion: Candesartan was beneficial for preventing cardiovascular events in high-risk 
patients. 
10:45 a.m. 
851-2 Detecting Myocardial lechemle From Four Bipolar 
Leads Reconstructed From the Unipoles That Are 
Potentially Available in Implanted Devices 
Azad Ghuran. Dan Wichtede, lan Little, Kamran Baig, Velislav Batchvarov, A John 
Camm, Charles Pumphrey, David Ward, Marek Malik, Cardiological Sciences, St. 
George's Hospital Medical School London, United Kingdom. 
Background: The technology to detect myocardial ischaemia using right-sided cardiac 
electrodes can be useful in implanted devices, such as cardiac pacemakers and implant- 
able cardioverters defibrillators. This study investigated the diagnostic accuracy of moni- 
toring myocardial ischaemia from intracardiac recordings during elective percutaneous 
coronary angioplasty. 
Method: Forty-eight patients were investigated with a total of 194 balloon inflations (23 
left anterior descending, 2 diagonals, 8 circumflex, 5 obtuse marginals and 23 right coro- 
nary arteries). Standard 12-lead ECGs were compared with reconstructed bipolar record- 
ings: pectoral-right ventricle (PEC-RV), superior vena cava and RV (SVC-RV), right 
atdum-RV (RA-RV) and coronary sinus-RV (CS-RV). 
Results: The graph below displays median of ST segment deviation from baseline in the 
respective leads during the first 30 seconds of balloon inflation, for all arteries. Compared 
to the best surface lead from the 12-lead ECG (V2), the bipolar leads were superior in 
detecting ischaemic ST changes (p<0.0001, Wilcoxon matched pairs test). 
Conclusion: Monitoring regional myocardial ischaemia, irrespective of the epicardial 
artery involved from right-sided intracardiac electrodes is feasible, and may be incorpo- 
rated into the algorithms of implanted devices to improve their diagnostic and therapeutic 
strategies. 
